Concepedia
Statistics
Publications
9
Citations
1.1K
H-Index
Active since
1987
Affiliations
New Frontier(Current)
Molecular Discovery (United Kingdom)
F L McCabe is an author at New Frontier specializing in medicine, pharmacology, and cancer pharmacology.
Publications per year
1987–1993
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.
F H Drake, JP Zimmerman, F L McCabe et al. · Journal of Biological Chemistry · 1987 · 284 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +14
Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase Inhibitors
K. B. Tan, Michael R. Mattern, W.-K. Eng et al. · JNCI Journal of the National Cancer Institute · 1989 · 172 citations
Medicine, Oncology, Pharmacology +10
Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
Michael R. Mattern, G A Hofmann, F L McCabe et al. · PubMed · 1991 · 149 citations
Medicine, Pharmacology, Radiation Oncology +17
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
Wai-Kwong Eng, F L McCabe, K. B. Tan et al. · Molecular Pharmacology · 1990 · 127 citations
Medicine, Oncology, Pharmacology +14
Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.
L B Grochow, Eric K. Rowinsky, Randall S. Johnson et al. · Drug Metabolism and Disposition · 1992 · 126 citations
Medicine, Pharmacokinetics, Pharmacology +16
1–5 of 9